Altınbaş A - Search Results

1

[Investigation of occult hepatitis B in HIV infected patients].

Altınbaş A, Ergünay K, Calık Başaran N, Alp A, Turgut D, Hasçelik G, Uzun Ö, Unal S. Altınbaş A, et al. Mikrobiyol Bul. 2011 Apr;45(2):353-8. Mikrobiyol Bul. 2011. PMID: 21644079 Turkish.

2

[Rapid development of anemia in a HIV-positive patient with alpha-thalassemia after zidovudine therapy].

Altinbaş A, Ozkaya G, Büyükaşik Y, Unal S. Altinbaş A, et al. Mikrobiyol Bul. 2007 Jul;41(3):473-6. Mikrobiyol Bul. 2007. PMID: 17933262 Turkish.

3

[Investigation of anti-R7V antibodies in HIV-infected patients under highly active antiretroviral therapy].

Ergünay K, Altinbaş A, Calik Başaran N, Unal S, Us D, Karabulut E, Ustaçelebi S. Ergünay K, et al. Among authors: altinbas a. Mikrobiyol Bul. 2008 Jul;42(3):413-9. Mikrobiyol Bul. 2008. PMID: 18822884 Turkish.

4

Alpha-1 antitrypsin deficiency in patients with chronic hepatitis.

Şımşek H, Pinar A, Altinbaş A, Alp A, Balaban YH, Büyükaşik Y, Özcebe O, Hasçelık G, Gedıkoğlu G, Tatar G. Şımşek H, et al. Among authors: altinbas a. Turk J Gastroenterol. 2012;23(5):569-73. Turk J Gastroenterol. 2012. PMID: 23161303 Free article.

5

Cutoff level to detect heterozygous alpha 1 antitrypsin deficiency in Turkish population.

Simsek H, Pinar A, Altinbas A, Alp A, Balaban YH, Buyukasik Y, Ozcebe O, Hascelik G, Gedikoglu G, Tatar G. Simsek H, et al. Among authors: altinbas a. J Clin Lab Anal. 2011;25(4):296-9. doi: 10.1002/jcla.20472. J Clin Lab Anal. 2011. PMID: 21786332 Free PMC article.

6

Spontaneous HBsAg seroconversion after severe flare of chronic hepatitis B infection.

Altinbas A, Yüksel I, Pamukcu M, Ekiz F, Basar O, Yüksel O. Altinbas A, et al. Ann Hepatol. 2010 Apr-Jun;9(2):194-7. Ann Hepatol. 2010. PMID: 20526016 Free article.

7

Hepatitis C Virus Infection in Pregnancy: An Update.

Altınbas S, Holmes JA, Altınbas A. Altınbas S, et al. Among authors: altinbas a. Gastroenterol Nurs. 2020 Jan/Feb;43(1):12-21. doi: 10.1097/SGA.0000000000000404. Gastroenterol Nurs. 2020. PMID: 31990870

8

Retrospective analysis of total direct medical costs associated with hepatitis B patients with oral antiviral versus pegylated interferon therapy in Turkey.

Altinbas A, Baser E, Burkan A, Ertugay E, Kariburyo MF, Baser O. Altinbas A, et al. J Viral Hepat. 2014 Nov;21(11):794-801. doi: 10.1111/jvh.12206. Epub 2014 Feb 18. J Viral Hepat. 2014. PMID: 24548474 Free article.

9

Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B.

Koklu S, Gulsen MT, Tuna Y, Koklu H, Yuksel O, Demir M, Guner R, Dogan Z, Kucukazman M, Poyrazoglu OK, Biyik M, Ozturk NA, Aydogan T, Coban S, Kocaman O, Sapmaz F, Gokturk SH, Karaca C, Demirezer A, Tanoglu A, Yildirim B, Altinbas A, Atak BM, Cosar AM, Alkan E; Other collaborators. Koklu S, et al. Among authors: altinbas a. Aliment Pharmacol Ther. 2015 Feb;41(3):310-9. doi: 10.1111/apt.13036. Epub 2014 Dec 4. Aliment Pharmacol Ther. 2015. PMID: 25982037 Free article.

10

Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B.

Ekiz F, Yüksel O, Koçak E, Yılmaz B, Altınbaş A, Çoban S, Yüksel I, Üsküdar O, Köklü S. Ekiz F, et al. Among authors: altinbas a. J Clin Lab Anal. 2011;25(3):162-5. doi: 10.1002/jcla.20450. J Clin Lab Anal. 2011. PMID: 21567462 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

159 results

Search Page